Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
Global Transfusion Diagnostics Market 2013 France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 26,000.00
... market entrants identify and evaluate emerging opportunities in the global transfusion diagnostic market during the next five years, and assist industry ... ; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood ...
September 2013
800 pages
Global Cancer Vaccines Pipeline Analysis
US$ 1,800.00
... has the largest share of the overall vaccines and specifically cancer vaccines market. This is followed by Europe and Asia. North America and ... process. Following parameters for each vaccine profile in development phase are covered in “Global Cancer Vaccines Pipeline Analysis” research report: Drug Profile ...
September 2013
345 pages
Competitor Analysis: Bruton’s Tyrosine Kinase (BTK) Inhibitors
US$ 132.00
The present Competitive Intelligence report about Bruton’s Tyrosine Kinase (BTK) Inhibitorsprovides a competitor evaluation in the field of small molecule-based inhibitors of Bruton’s Tyrosine Kinase (BTK) for the treatment of B-cell related hematologic malign ancies and autoimmune diseases as of August 2013. ...
August 2013
13 pages
Competitor Analysis: Focal Adhesion Kinase (FAK) Inhibitors
US$ 132.00
The present Competitive Intelligence report about Focal Adhesion Kinase (FAK) Inhibitors provides a competitor evaluation in the field of small molecule-based ... and development of selective and multi-target small molecule Focal Adhesion Kinase (FAK) inhibitors in oncology. In addition, the report lists company ...
August 2013
13 pages
Global Cancer Diagnostics Market 2013 France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 26,000.00
... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer ...
August 2013
1200 pages
In Vitro Diagnostics: World Market Outlook 2013-2023
US$ 2,635.00
... gives you these advantages: Revenues to 2023 for IVD products at world level, with forecasting of seven submarkets - assess prospects for investments ... - explore activities, results, R&D, and outlooks for future success. In Vitro Diagnostics: World Market Outlook 2013-2023 gives independent analysis. There ...
August 2013
137 pages
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
US$ 3,995.00
... cells (CTCs) are believed to detach from primary or secondary tumors and enter the bloodstream, traveling to distant organs and forming new ... process of metastasis; however, their biology is still not entirely elucidated. Circulating tumor cells have tremendous utility in cancer research, aiding scientists ...
August 2013
164 pages
Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors
US$ 199.00
The present Competitive Intelligence report about Anaplastic Lymphoma Kinase (ALK) Inhibitors provides a competitor evaluation in the field of small molecule and antibody-based inhibitors of Anaplastic Lymphoma Kinase (ALK) for the treatment of solid tumors as of August 2013. Purchase ...
August 2013
17 pages
European Clinical Chemistry and Immunodiagnostic Market 2013 France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 15,760.00
... five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and a feature ...
August 2013
900 pages
Global Clinical Chemistry and Immunodiagnostic Market 2013 France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 26,800.00
... five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature ...
August 2013
1115 pages
Competitor Analysis: Poly-Adenyl-Ribose Polymerase (PARP) Inhibitors
US$ 199.00
The present Competitive Intelligence report about Poly-Adenyl-Ribose Polymerase (PARP) Inhibitors provides a competitor evaluation in the field of small molecule ... that repair DNA damage. Despite the recent failure of Sanofi’s PARP inhibitor iniparib, presentation of results from clinical studies with other ...
August 2013
22 pages
Research Report on Global and China In-vitro Diagnostic Reagent Industry, 2013-2017
US$ 2,200.00
... reached USD 25 to USD 30. Therefore, there is a wide growth space for China's in-vitro diagnostics. CRI predicts that the growth rate of the ... Reagent Industry Major In-vitro Diagnostic Reagent Manufacturers in Global and China Markets Forecast on the Development of In-vitro Diagnostic Reagent Industry The ...
August 2013
50 pages
Ovarian Cancer Pipeline Analysis
US$ 1,800.00
... when purchasing Hard Copy License depending on the location. “Ovarian Cancer Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... reader to identify and understand the therapeutics associated with the Ovarian Cancer disease. The information for particular drug in development process ...
August 2013
660 pages
Pancreatic Cancer Drug Pipeline Analysis
US$ 1,800.00
... purchasing Hard Copy License depending on the location. “Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... . Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, ...
August 2013
515 pages
Hepatitis C Drug Pipeline Analysis
US$ 1,800.00
... when purchasing Hard Copy License depending on the location. “Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, ...
August 2013
700 pages
Global Food Safety Testing Market Analysis
US$ 1,200.00
... being imported raise doubts over the safety of the food available in the market. Unsafe food, which contains contaminants, may prove ... either naturally or as a result of poor production practice. According to RNCOS’ study “Global Food Safety Testing Market Analysis,” a growing number of participants in the ...
July 2013
80 pages
Global Infectious Disease Testing Market 2013 France, Germany, Italy, Japan, Spain, UK, US Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 26,000.00
... designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The report provides market segmentation analysis of over ...
July 2013
World Cancer Diagnostic Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
US$ 26,000.00
... and provides forecasts for 40 tumor markers by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and individual test: Regions: Global, Europe Countries: France, Germany, Italy ...
July 2013
World Clinical Chemistry and Immunodiagnostic Markets: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
US$ 26,800.00
... Sections: Assays, Competitors, Instrumentation, Technologies Market Segments: Home/Self Testing, Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Point-of-Care Test Groups: Diabetes/Glucose Testing, Drugs of Abuse/POC, Endocrine, Immunoproteins, Lipids, TDM, Tumor Markers/Specialty Chemistry
July 2013
World Coagulation Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
US$ 26,000.00
... and provides forecasts for 40 major procedures by country and market segment, as well as sales and market shares for reagent and instrument ... . The report is available by region, country, section, market segment and individual test: Regions: Global, Europe Countries: Belorussia, Benelux, France, Germany, ...
July 2013
World Hematology and Flow Cytometry Markets: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
US$ 25,760.00
This new report from Venture Planning Group contains 700 pages, 250 tables and provides forecasts for 40 tests by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, and market segment: Regions: Global, ...
July 2013
Cancer Monoclonal Antibodies Market Forecast to 2017
US$ 1,500.00
... in the pipeline. According to RNCOS' report, "Cancer Monoclonal Antibodies Market Forecast to 2017", the market for cancer mAbs is estimated at US$ 24 Billion, and ... approval of these drugs will drive a major change in the market in terms of market share of current drugs. Finally, RNCOS concludes its report ...
July 2013
105 pages
Diabetes: Battle for ascendancy escalates in expanding market – KOL Insight
US$ 4,995.00
... ; Novo Nordisk) recent US failure, the exponential market growth makes diabetes one of the most attractive opportunities in Pharma. Competition in the major ... market share from the gold standard treatments. ‘Therapy Trends: Diabetes’ is compiled from exclusive, in-depth interviews with the world’s leading ...
July 2013
Lateral Flow Technology And The Future Of Point Of Care Diagnostics, 2nd Edition
US$ 4,200.00
... reduce the cost of both device development and care. This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes ... acknowledging the reality of payors’ emphasis on cost/benefit analysis for new technologies. Current sales and predictions for 2017 sales are provided for the ...
July 2013
210 pages
Research Report on Global and China Blood Product Industry, 2013-2017
US$ 2,200.00
... Through This Report: Status of Global Blood Product Industry Status of China Blood Product Industry and Products Economy and Policy Environment ... Blood Product Industry Operation Status of Major Blood Product Manufacturers in China Development Trend of Blood Product Industry The Following Enterprises and ...
July 2013
60 pages
Global Blood Typing, Grouping and Infectious Disease Screening Market 2013: France, Germany, Italy, Japan, Spain, UK, US-- Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 26,000.00
... and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and ... Banks Current and Emerging Products - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and ...
July 2013
European Blood Typing, Grouping and Infectious Disease Screening Market 2013: France, Germany, Italy, Spain, UK-- Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 15,760.00
... and potential market entrants identify and evaluate emerging opportunities in the European blood banking market during the next five years, and assist ... Current and Emerging Products - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and ...
July 2013
